Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

NCT00461292 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

275

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

BIOLOGICAL: botulinum toxin Type A (200U)
BIOLOGICAL: botulinum toxin Type A (300U)
OTHER: Normal saline (Placebo); botulinum toxin Type A (200U)
OTHER: Normal saline (Placebo); botulinum toxin Type A (300U)

Sponsor

Allergan